Skip to main content
OpenTrials
Completed

NCT Number: NCT01871298

Drug User Internet and Mobile Tech Use

The purpose of this exploratory study is to examine factors associated with frequency and type of internet and mobile technology use among illegal drug users, specifically use of internet and text-messaging to obtain health care information and engage in health care utilization, specifically human immunodeficiency virus (HIV) prevention and treatment services. We will target high drug activity neighborhoods in New York City and enroll participants recruited through targeted street outreach. All participants (n=336) will undergo an audio computer-assisted self-interview (ACASI) that will assess sociodemographics, health care access and utilization, sex/drug use behavior, health status, and characteristics of general and health-related internet/mobile technology use including factors that promote or hinder use. Participants identified as using the internet ≥1/month (n=151) will return for a 4-week ACASI to report on use of the pilot website (which will largely display information currently available in the community in print/ pamphlet/ video form).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Drug Abuse Illicit

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Columbia University Medical Center

New York, 10032, United States

About this study

At the enrollment visit participants deemed eligible after screening will be consented, and given a 30 minute baseline ACASI survey. At the end of the baseline visit, those participants who reported internet use at least 1x/month (in the past month) will be offered participation in the Pilot Website Evaluation Component. For this component, participants will be instructed on how to use an educational website with health resources. Their use of the website will be tracked. They will be given an appointment to return in 4-weeks for a follow up survey at the pharmacy and a 2-week locator call.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • any lifetime illegal drug use
  • age > 18

Exclusion criteria

  • none

Treatment and study plan

Pilot Website Evaluation Component

Other

The pilot health website will contain educational health information such as: health-related videos, searchable map of HIV prevention and other needed health and social services, and the option to register for automatic text message updates on relevant health information.

Primary outcomes

  1. Percent of participants who use the pilot website

    Time frame: 4 weeks

Secondary outcomes

  1. Percent of participants who use the internet

    Time frame: Baseline

  2. Percent of participants who use the internet at least once a month

    Time frame: Baseline

  3. Percent of participants who use the internet for health-related purposes

    Time frame: Baseline

  4. Percent of participants who are willing to use internet or mobile technology for health-related purposes

    Time frame: Baseline

  5. Percent of participants who sign up for receipt of automatic text message updates on relevant health information

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Exploratory Study of Drug User Health-related Internet and Mobile Technology Use

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jun 6, 2013
Registry last updated
Nov 26, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.